Drugs and Medical Pharmacology

Peter Doshi, Postdoctoral Fellow in Comparative Effectiveness Research, Johns Hopkins University Medical School, US, talks about "Accuracy, Completeness, and Transparency: lessons from Tamiflu experience"

Other readings:

• Doshi P. Neuraminidase inhibitors—the story behind the Cochrane review. BMJ. 2009;339:b5164. doi:10.1136/bmj.b5164
   
• The missing data that cost $20bn​ Tamiflu campaign: Tamiflu data: Who saw what when. (2018). Retrieved from http://www.bmj.com/tamiflu
  ​
• Tom Jefferson - “The neuraminidase inhibitors evidence of harms – in context.” CEBM. http://www.cebm.net/blog/2016/06/30/tom-jefferson-neuraminidase-inhibitors-evidence-harms-context/. Published June 30, 2016. Accessed January 23, 2018.